If you read the sticky note post #331 there is a l
Post# of 72440
If you read the sticky note post #331 there is a line by the author at the end of paragraph 1 on page 7 that states because this class of chemistry has never been used in medicine, the patent for Kevetrin literally covers tens of thousands of possible future chemical combinations for new drugs.
This sets up Kevetrin as the broad platform base for a myriad of cancer related products and I thought Prurisol has been mentioned as having the potential to establish itself as the broad platform base for auto immune afflictions. Hope I am not erroneous on the above assumption, but if it is true, then the value of CTIX IMO seems to be possibly far above the $10-12BB Leo thru out in a statement awhile back. A major pharma could base their whole future R& D around combos derived from just these two products.
Anyway, exciting times and fingers crossed for successful trials.